Health Canada has announced its approval of Yervoy(TM) (ipilimumab)!!!!!

Forums Cutaneous Melanoma Community Health Canada has announced its approval of Yervoy(TM) (ipilimumab)!!!!!

  • This topic is empty.
  • Post
    jim Breitfeller
    Participant

      VANCOUVER, BRITISH COLUMBIA, Feb 07, 2012 (MARKETWIRE via COMTEX)

      — Health Canada has announced its approval of Yervoy(TM) (ipilimumab) to treat metastatic, or advanced, melanoma. It is the first new treatment for the disease in more than a decade, and is the only medicine proven to significantly extend the lives of patients living with the disease. Melanoma is the deadliest form of skin cancer and one of the fastest growing cancers in Canada.

       

      Best regards,

       

      Jimmy B.

      VANCOUVER, BRITISH COLUMBIA, Feb 07, 2012 (MARKETWIRE via COMTEX)

      — Health Canada has announced its approval of Yervoy(TM) (ipilimumab) to treat metastatic, or advanced, melanoma. It is the first new treatment for the disease in more than a decade, and is the only medicine proven to significantly extend the lives of patients living with the disease. Melanoma is the deadliest form of skin cancer and one of the fastest growing cancers in Canada.

       

      Best regards,

       

      Jimmy B.

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics